Polygenic polymorphism is associated with NKG2A repertoire and influences lymphocyte phenotype and function.

Autor: Le Luduec JB; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Kontopoulos T; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Panjwani MK; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Sottile R; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Humanitas Clinical and Research Center, Pieve Emanuele, Italy., Liu H; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY., Schäfer G; Genotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany., Massalski C; Genotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany., Lange V; Genotyping Laboratory, Deutsche Knochenmarkspenderdatei Life Science Lab, Dresden, Germany., Hsu KC; Human Oncology and Pathogenesis Program, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY.; Department of Medicine, Weill Cornell Medical College, New York, NY.; Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY.

Publikováno v: Blood advances [Blood Adv] 2024 Oct 22; Vol. 8 (20), pp. 5382-5399.

Single-Cell Profiling Reveals a Naive-Memory Relationship between CD56 ^bright and Adaptive Human Natural Killer Cells.

Autor: Panjwani MK, Grassmann S, Sottile R, Le Luduec JB, Kontopoulos T, van der Ploeg K, Sun JC, Hsu KC

Publikováno v: BioRxiv : the preprint server for biology [bioRxiv] 2023 Sep 24. Date of Electronic Publication: 2023 Sep 24.

Modeling of Efficient Control Strategies for LCC-HVDC Systems: A Case Study of Matiari-Lahore HVDC Power Transmission Line.

Autor: Ahmed A; School of Electrical and Electronics Engineering, North China Electric Power University, Beijing 102206, China., Khan D; Department of Electrical Engineering, Indus University, Karachi 75300, Pakistan., Khan AM; Department of Electrical Engineering, Indus University, Karachi 75300, Pakistan., Mustafa MU; School of Electrical and Electronics Engineering, North China Electric Power University, Beijing 102206, China., Panjwani MK; Department of Electrical Engineering, Sukkur IBA University, Sukkur 65200, Pakistan., Hanan M; School of Electrical and Electronics Engineering, North China Electric Power University, Beijing 102206, China., Agyekum EB; Department of Nuclear and Renewable Energy, Ural Federal University, 620002 Ekaterinburg, Russia., Uhunamure SE; Faculty of Applied Sciences, Cape Peninsula University of Technology, P.O. Box 652, Cape Town 8000, South Africa., Edokpayi JN; Faculty of Science, Engineering and Agriculture, University of Venda, Private Bag X5050, Thohoyandou 0950, South Africa.

Publikováno v: Sensors (Basel, Switzerland) [Sensors (Basel)] 2022 Apr 06; Vol. 22 (7). Date of Electronic Publication: 2022 Apr 06.

Human cytomegalovirus expands a CD8 ⁺ T cell population with loss of BCL11B expression and gain of NK cell identity.

Autor: Sottile R; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Panjwani MK; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Lau CM; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Daniyan AF; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Tanaka K; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Barker JN; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Brentjens RJ; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Sun JC; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Immunology and Microbial Pathogenesis, Weill Cornell Medical College, New York, NY, USA., Le Luduec JB; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA., Hsu KC; Immunology Program, Sloan Kettering Institute, Memorial Sloan Kettering Cancer Center, New York, NY, USA.; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY, USA.

Publikováno v: Science immunology [Sci Immunol] 2021 Sep 24; Vol. 6 (63), pp. eabe6968. Date of Electronic Publication: 2021 Sep 24.

Checkpoint Blockade Reverses Anergy in IL-13Rα2 Humanized scFv-Based CAR T Cells to Treat Murine and Canine Gliomas.

Autor: Yin Y; The Fourth Section of Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China.; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Boesteanu AC; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Binder ZA; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Xu C; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., Reid RA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Rodriguez JL; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Cook DR; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Thokala R; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Blouch K; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., McGettigan-Croce B; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Zhang L; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Konradt C; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Cogdill AP; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Panjwani MK; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., Jiang S; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Migliorini D; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., Dahmane N; Department of Neurological Surgery, Weill Cornell Medicine, New York, NY 10065, USA., Posey AD Jr; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., June CH; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., Mason NJ; Department of Clinical Sciences and Advanced Medicine, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Parker Institute for Cancer Immunotherapy, Philadelphia, PA 19104, USA., Lin Z; The Fourth Section of Department of Neurosurgery, The First Affiliated Hospital, Harbin Medical University, Harbin 150001, China., O'Rourke DM; Department of Neurosurgery, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA., Johnson LA; Center for Cellular Immunotherapies, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.; Department of Pathology and Laboratory Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.

Publikováno v: Molecular therapy oncolytics [Mol Ther Oncolytics] 2018 Aug 28; Vol. 11, pp. 20-38. Date of Electronic Publication: 2018 Aug 28 (Print Publication: 2018).